semaglutide sarcopenia Therapy and Accelerated in Older Adults with Type 2 Diabetes: A 24-Month Retrospective Cohort Study Obesity pharmacotherapy in older adults:

Most individuals begin noticing appetite reduction within the first week or two of starting semaglutide, though weight loss typically becomes measurable after 4-6 weeks of consistent therapy

The efficacy of the new pharmacotherapies will allow clinicians to treat obesity towards individualised treatment targets, similar to what is happening with other chronic diseases such as T2D or dyslipidaemia

For example, a 4S battery has four cells, each contributing 3.7V nominally, resulting in 14.8V

Most of that is for on-label use to treat obesity, but more and more endos are prescribing them off-label because of the positive results for BG management